skip to Main Content
Search
Submit
×
Close search
Home
Hemp Background
Technology
Bio-Fuels
COVID-19 Research
Territories & Partners
Investors
Company Timeline
Directors & Management
Share Structure
Trading
Financial Statements
Chinese version
News & Media
News Releases
Asia Green In the Media
Media Backgrounders
Contact Us
Search
Timeline Stories
Enters Agreement With Swysh Inc. to obtain Technology License for Medical Products For Asia Region
May 25, 2020
asiacannabis1958
March 2020
AsiaCanCorp
previous post:
Confirms Patent Application Filed by Swysh Inc. in relation to Anti-Viral Treatments
next post:
Publicly listed with IPO as CSE:ASIA
Back To Top
Search
Submit
LATEST NEWS
Asia Green Biotechnology Corp. Announces Passing of Johannes Kingma
Asia Green Biotechnology Director: Bringing Canadian Cannabis Expertise to Asia (Investing News Network Interview)
Asia Green Biotechnology Corp. And Inplanta Biotechnology Ltd. Announce Grant Of Full Registration Of “Bountiful” Hemp Cultivar
Asia Green Biotechnology Corp. Enters Memorandum Of Agreement With Agricultural College In Cambodia To Evaluate Hemp Production Potential
CTV: Medicinal cannabis mouthwash could help combat COVID-19
Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc.
Forbes: ‘Cannabis Treats COVID-19’ Rallied Weed Stocks: Cannabis Could Aid Pandemic—If Someone Pays To Find Out
Asia Green Biotechnology Corp. Enters Technology License Agreement with Pathway Rx Inc. for Asia Region and Agrees to Assist in Initiating Clinical Trials
Covid-19 & Cannabis Research
The GrowthOp: This Alberta scientist received worldwide attention for his cannabis and COVID-19 study. But getting funding and a clinical trial going in Canada remains a massive challenge